September 18, 2017 04:56 AM EDTUpdated 09:46 AM
Financing

Sail­ing past the $2B mark, Flag­ship sets course for $500M-plus biotech fund, un­veils a new start­up

John Carroll

Editor & Founder

Over the past few years Flag­ship Pi­o­neer­ing has gam­bled hun­dreds of mil­lions of dol­lars on some of the most in­trigu­ing bets in big sci­ence, re­cruit­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times